Lung-targeted lentiviral vector mediates passive immunisation against influenza

Lung-targeted lentiviral vector mediates passive immunisation against influenza

Bibliographic Details
Main Authors:	Tan, T, Rijal, P, Townsend, A, Hyde, S, Gill, D
Format:	Conference item
Published:	Mary Ann Liebert 2018

Similar Items

Lung-targeting lentiviral vector for passive immunisation against influenza
by: Tan, TK, et al.
Published: (2020)

431. Lung antibody factory for passive immunisation against influenza
by: Tan, T, et al.
Published: (2016)

Lentiviral-mediated expression of monoclonal antibodies in the lung to protect against influenza
by: Du, Y, et al.
Published: (2020)

Development of recombinant Adeno-Associated Viral vector (rAAV) for passive immunisation against ebola
by: Tan, T, et al.
Published: (2017)

Development of viral vectors for passive immunisation against influenza
by: Tan, TK
Published: (2017)

A method for assessing the distribution of eGFP expressing cells in the mouse lung following lentiviral vector transduction
by: Munday, R, et al.
Published: (2018)

Investigating pseudotyped lentiviral vectors for gene delivery to the lung
by: Munday, RJ
Published: (2021)

High levels of native eGFP detected following F/HN lentiviral vector transduction of a variety of lung models
by: Munday, R, et al.
Published: (2019)

Immunisation against influenza during pregnancy.
by: Knight, M, et al.
Published: (2012)

Respiratory immunisation and mucosal immunity against influenza
by: Martini, V
Published: (2022)

Cardiac transplantation and immunisation against Haemophilus influenzae.
by: Barbour, M, et al.
Published: (1993)

Lentiviral and AAV-mediated expression of palivizumab offer protection against Respiratory Syncytial Virus infection
by: Antepowicz, A, et al.
Published: (2021)

Cholesterol as an enhancer of lentiviral vector production in serum-free transient transfection
by: Gelinas, J, et al.
Published: (2013)

Assessment of selected media supplements to improve F/HN lentiviral vector production yields
by: Gélinas, J, et al.
Published: (2017)

Rapid determination of rSIV.F/HN lentiviral vector titre
by: Conway, CC, et al.
Published: (2020)

Large-scale, high-throughput production of lentiviral vectors for multiple disease applications
by: Ashworth, R, et al.
Published: (2018)

Immunisation against influenza during pregnancy The benefits outweigh the risks
by: Knight, M, et al.
Published: (2012)

Lentiviral vector pseudotyped with sendai virus F and HN proteins uses sialylated glycan receptors to efficiently target human airway cells
by: Munday, RJ, et al.
Published: (2020)

Use of pseudotyped, replication deficient influenza to facilitate testing of gene delivery strategies for treatment of highly infectious diseases
by: Tan, T, et al.
Published: (2018)

Effective gene therapy with nonintegrating lentiviral vectors.
by: Yáñez-Muñoz, R, et al.
Published: (2006)

Development of lentiviral vector respiratory tract dosing methods in anticipation of rodent GLP toxicology assessment
by: Sinadinos, A, et al.
Published: (2021)

Intranasal lentiviral vector-mediated antibody delivery confers reduction of SARS-CoV-2 infection in elderly and immunocompromised mice
by: Du, Y, et al.
Published: (2022)

Viral vectors for immunisation against potassium channel Kv1.2
by: McKnight, K, et al.
Published: (2005)

Enhanced lentiviral production through rational design of mammalian host cells
by: Hyde, S, et al.
Published: (2016)

Gene therapy applications of non-human lentiviral vectors
by: Munis, AM
Published: (2020)

Lentiviral vector for p47phox gene therapy
by: Haenseler, W, et al.
Published: (2013)

Generation of lentiviral-mediated shRNA vectors to inhibit the expression of caspase-1 and Pycard/ASC in dendritic cells.
by: Tan, Bee Kim.
Published: (2010)

F/HN pseudotyped lentiviral vector uses alpha 2,3 sialylated N-acetyllactosamine to efficiently transduce human airway cells
by: Munday, RJ, et al.
Published: (2022)

Gene transfer vector development to treat lung disease: The use of a dual-function Lentiviral vector containing ENaC RNAi and the CFTR gene to treat Cystic Fibrosis lung disaease
by: Harding-Smith, R
Published: (2014)

Expression profile of optimised SIV vector in the mouse lung at early timepoints post-delivery
by: Pringle, I, et al.
Published: (2018)

Production of lentiviral vector with polycistronic transcripts for reprogramming of mouse fibroblast cells
by: Al Abbar, Akram, et al.
Published: (2018)

Enhancement of lentiviral vector production through alteration of virus-cell interactions
by: Gelinas, J
Published: (2016)

HIV-1 conserved mosaics delivered by regimens with integration-deficient, DC-targeting lentiviral vector induce robust T cells
by: Hanke, T, et al.
Published: (2016)

Sendai F/HN pseudotyped lentiviral vector transduces human ciliated and non-ciliated airway cells using α 2,3 sialylated receptors
by: Munday, RJ, et al.
Published: (2022)

Challenges in immunisation against bacterial infection in children.
by: Trück, J, et al.
Published: (2010)

597: Protocol development for mouse toxicology studies using lentiviral gene therapy
by: Sinadinos, A, et al.
Published: (2021)

Long-term effect of neuronal nitric oxide synthase over-expression on cardiac neurotransmission mediated by a lentiviral vector.
by: Wang, L, et al.
Published: (2009)

Expression profile of optimised SIV vector in the mouse lung at early timepoints post-delivery
by: Pringle, I, et al.
Published: (2018)

Conditional mouse lung cancer models using adenoviral or lentiviral delivery of Cre recombinase
by: DuPage, Michel J., et al.
Published: (2014)

Development of an inducible single lentiviral vector-based microRNA knockdown construct.
by: Ip, Jun Yu.
Published: (2013)